Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Kitamura

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1986
[A case of adrenal ganglioneuroblastoma--cytology of the bone marrow aspirate as an important evidence of the diagnosis]K Kitagawa, K Goto, M Nishida, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1990
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)]T Shiraishi, Y Nio, S Imai, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1990
[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)]T Shiraishi, Y Nio, S Imai, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 1, 1986
[A case of adrenal ganglioneuroblastoma--cytology of the bone marrow aspirate as an important evidence of the diagnosis]K Kitagawa, K Goto, M Nishida, et al.
Nihon Gan Chiryo Gakkai Shi|April 20, 1990
[A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)]T Shiraishi, Y Nio, S Imai, et al.
Nihon Gan Chiryo Gakkai Shi|May 20, 1990
[A double blind study to evaluate the optimal dose and its frequency for oral administration of OK-432 (picibanil) by immunological parameters (the 2nd report)]T Shiraishi, Y Nio, S Imai, et al.
Pageof 6